Share This Page
Drug Price Trends for GNP TUSSIN DM
✉ Email this page to a colleague

Average Pharmacy Cost for GNP TUSSIN DM
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
GNP TUSSIN DM 200-20 MG/20 ML | 46122-0704-26 | 0.01953 | ML | 2025-02-19 |
GNP TUSSIN DM 200-20 MG/20 ML | 46122-0704-34 | 0.01636 | ML | 2025-02-19 |
GNP TUSSIN DM MAX LIQUID | 46122-0541-34 | 0.01758 | ML | 2025-02-19 |
GNP TUSSIN DM 200-20 MG/20 ML | 46122-0704-26 | 0.01903 | ML | 2025-01-22 |
GNP TUSSIN DM MAX LIQUID | 46122-0541-34 | 0.01748 | ML | 2025-01-22 |
GNP TUSSIN DM 200-20 MG/20 ML | 46122-0704-34 | 0.01630 | ML | 2025-01-22 |
GNP TUSSIN DM MAX LIQUID | 46122-0541-34 | 0.01764 | ML | 2024-12-18 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for GNP Tussin DM
Overview of GNP Tussin DM
GNP Tussin DM is a cough suppressant and expectorant medication, containing dextromethorphan hydrobromide and guaifenesin. It is designed to temporarily relieve coughs due to minor throat and bronchial irritation, and to help loosen phlegm and thin bronchial secretions[4].
Market Size and Growth
The global dextromethorphan market, which includes products like GNP Tussin DM, was valued at USD 487.25 million in 2022. It is projected to reach USD 587.31 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period of 2023 to 2030[1].
Key Drivers of Market Growth
- Increasing Prevalence of Cough Related Conditions: The rising prevalence of respiratory conditions such as the common cold, flu, bronchitis, and allergies drives the demand for cough medications like GNP Tussin DM[1].
- Growing Consumer Awareness and Self Medication: Increased access to healthcare information and self-medication practices have led to higher consumer awareness and use of over-the-counter medications, including dextromethorphan-containing products[1].
Market Segmentation
The global dextromethorphan market is segmented based on several factors:
- Product Type: Over-the-counter (OTC) products dominate the market, with GNP Tussin DM falling under this category[1].
- Age Group: The market is segmented into pediatric and adult age groups. GNP Tussin DM is typically used by adults, although there are pediatric formulations available[1].
- Dosage Form: GNP Tussin DM is available in liquid form, which is one of the common dosage forms along with tablets and others[1].
- Route of Administration: The oral route is the primary method of administration for GNP Tussin DM[1].
- End Users: The product is used in various settings including hospitals, specialty clinics, homecare, and others[1].
- Distribution Channel: GNP Tussin DM is available through hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels[1].
Regional Market Analysis
- North America: This region dominates the global dextromethorphan market due to a strong base of healthcare facilities and the presence of major market players. The high demand for OTC cough medications in this region contributes significantly to the market size[1].
- Asia-Pacific: This region is expected to witness significant growth during the forecast period due to government initiatives, increasing healthcare facilities, and a large population pool[1].
Price Projections
General Pharmaceutical Price Trends
The overall pharmaceutical market is expected to see a price inflation rate of 3.81% in 2025, according to Vizient's Pharmacy Market Outlook. This inflation is driven by factors such as expanding indications for previously approved medications and the introduction of high-cost cell and gene therapies[3].
Specific to Dextromethorphan Market
While the general pharmaceutical price inflation rate provides a broader context, the specific price trends for dextromethorphan products like GNP Tussin DM are influenced by market demand, competition, and regulatory factors. Given the stable demand and relatively low production costs, the prices of dextromethorphan products are likely to remain competitive.
Current Pricing
As of the current market, GNP Tussin DM Max Strength Liquid is priced around $8.29 for an 8oz bottle, indicating a relatively affordable pricing strategy[5].
Future Price Projections
- Market Competition: The presence of multiple brands and generic options in the market is likely to keep prices competitive. However, any significant increase in raw material costs or manufacturing expenses could lead to slight price adjustments.
- Regulatory Factors: Changes in regulatory policies or healthcare reimbursement rates could impact the pricing of OTC medications like GNP Tussin DM.
- Consumer Demand: Continued high demand for cough suppressants and expectorants will likely maintain current price levels or result in minimal increases.
Given these factors, it is reasonable to expect that the price of GNP Tussin DM will remain relatively stable or see minor increases in line with the overall pharmaceutical price inflation rate.
Key Takeaways
- The global dextromethorphan market is growing at a CAGR of 4.8% from 2023 to 2030.
- Over-the-counter products dominate the market, driven by high demand and consumer awareness.
- North America and Asia-Pacific are key regions driving market growth.
- Prices are expected to remain competitive with minor adjustments based on market and regulatory factors.
- The current price of GNP Tussin DM is around $8.29 for an 8oz bottle, reflecting a competitive pricing strategy.
FAQs
What is the current market size of the global dextromethorphan market?
The global dextromethorphan market was valued at USD 487.25 million in 2022[1].
What is the projected growth rate of the global dextromethorphan market?
The market is expected to grow at a CAGR of 4.8% from 2023 to 2030[1].
Which region dominates the global dextromethorphan market?
North America dominates the global dextromethorphan market due to a strong base of healthcare facilities and the presence of major market players[1].
What are the key drivers of the market growth for dextromethorphan products?
The increasing prevalence of cough-related conditions and growing consumer awareness and self-medication practices are key drivers of market growth[1].
How is GNP Tussin DM typically administered?
GNP Tussin DM is administered orally, typically in liquid form[4].
What is the current price of GNP Tussin DM Max Strength Liquid?
The current price of GNP Tussin DM Max Strength Liquid is around $8.29 for an 8oz bottle[5].
Sources
- Data Bridge Market Research: Global Dextromethorphan Market – Industry Trends and Forecast to 2030.
- CVS Health: CVS Health Non Drowsy Tussin DM Cough & Chest Congestion.
- Vizient, Inc.: Vizient projects drug price inflation at 3.81%.
- Drugs.com: Tussin DM: Package Insert / Prescribing Information.
- Amwell Pharmacy: GNP TUSSIN DM MAX STRENGTH LIQUID 8OZ.
More… ↓